| |
|
|
|
|
|
|
|||
|
A Rambaldi, M Terao, S Bettoni, R Bassan, R Battista, T Barbui and E Garattini
Istituto di Ricerche, Farmacologiche Mario Negri, Milano, Italy.
Paroxysmal nocturnal hemoglobinuria (PNH) and the stable phase of chronic
myelogenous leukemia (CML) are the two hematological conditions known to be
associated with low levels of leukocyte alkaline phosphatase (LAP) activity
in peripheral blood polymorphonuclear cells (PMN). LAP mRNA levels were
determined in PMN from PNH and CML patients by RNA blotting analysis. In
CML, LAP mRNA is undetectable, suggesting either decreased transcription or
rapid degradation of the message. Contrarily, in PNH normal or high levels
of LAP mRNA are present. This latter finding supports the concept of a
deficit in the anchorage of the protein to the plasma membrane through the
glycolipid pathway, even though other post-transcriptional mechanisms could
be involved.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1989 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||